Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

BATESVILLE REGIONAL MEDICAL CENTER, INC.

NPI: 1447784871 · BATESVILLE, MS 38606 · General Acute Care Hospital · NPI assigned 04/12/2017

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official CLAPP, STEVE controls 11+ related entities in our dataset. Read more

$87K
Total Medicaid Paid
21,355
Total Claims
8,939
Beneficiaries
70
Codes Billed
2018-01
First Month
2020-02
Last Month

Provider Details

Authorized OfficialCLAPP, STEVE (PRESIDENT)
NPI Enumeration Date04/12/2017

Related Entities

Other providers sharing the same authorized official: CLAPP, STEVE

ProviderCityStateTotal Paid
CLARKSDALE REGIONAL PHYSICIANS, LLC CLARKSDALE MS $308K
RUSSELLVILLE PHYSICIANS LLC RUSSELLVILLE AL $304K
LAKELAND PHYSICIANS LLC HALEYVILLE AL $284K
BATESVILLE REGIONAL PHYSICIANS LLC BATESVILLE MS $202K
AMORY REGIONAL MEDICAL CENTER, INC. AMORY MS $166K
BATESVILLE REGIONAL MEDICAL CENTER, INC. BATESVILLE MS $15K
CLARKSDALE REGIONAL PHYSICIANS, LLC CLARKSDALE MS $15K
AMORY REGIONAL PHYSICIANS,LLC AMORY MS $10K
CLARKSDALE REGIONAL PHYSICIANS, LLC CLARKSDALE MS $3K
CLARKSDALE REGIONAL MEDICAL CENTER, INC. CLARKSDALE MS $2K
BATESVILLE REGIONAL MEDICAL CENTER, INC. BATESVILLE MS $0.00

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 426 $45K
2019 18,073 $39K
2020 2,856 $3K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 1,232 695 $62K
99284 Emergency department visit for the evaluation and management, high severity 645 364 $10K
D7140 Extraction, erupted tooth or exposed root 480 90 $5K
41899 Unlisted procedure, dentoalveolar structures 560 315 $2K
D0272 Bitewings - two radiographic images 71 40 $1K
D2930 Prefabricated stainless steel crown - primary tooth 2,819 293 $1K
D2934 399 70 $838.25
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 264 143 $766.68
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 418 221 $668.20
D3220 Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction 1,982 289 $632.32
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 241 125 $467.97
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 156 83 $426.05
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 407 228 $389.20
D2391 Resin-based composite - one surface, posterior, primary or permanent 163 31 $341.60
D0220 Intraoral - periapical first radiographic image 99 55 $205.27
96361 Intravenous infusion, hydration; each additional hour 159 82 $189.84
96375 Therapeutic injection; each additional sequential IV push 125 61 $189.84
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 276 157 $119.04
85025 Blood count; complete (CBC), automated, and automated differential WBC count 833 459 $91.94
71046 Radiologic examination, chest; 2 views 23 13 $50.72
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 226 123 $45.51
80053 Comprehensive metabolic panel 759 411 $43.45
99281 Emergency department visit for the evaluation and management, self-limited or minor 116 72 $41.77
80048 Basic metabolic panel (calcium, ionized) 144 79 $33.84
D1120 Prophylaxis - child 176 103 $30.12
D1206 Topical application of fluoride varnish 188 109 $22.42
87086 Culture, bacterial; quantitative colony count, urine 216 126 $17.94
84703 185 107 $15.04
87807 86 51 $11.99
81003 516 294 $11.20
87040 26 12 $10.32
J3490 Unclassified drugs 249 125 $0.22
J2405 Injection, ondansetron hydrochloride, per 1 mg 1,509 536 $0.00
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 56 30 $0.00
87653 27 15 $0.00
86900 21 15 $0.00
84702 124 71 $0.00
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 179 97 $0.00
J2270 Injection, morphine sulfate, up to 10 mg 44 26 $0.00
J7510 Prednisolone oral, per 5 mg 25 12 $0.00
70450 Computed tomography, head or brain; without contrast material 33 17 $0.00
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 24 15 $0.00
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 19 14 $0.00
80061 Lipid panel 59 34 $0.00
87186 23 15 $0.00
D9999 Unspecified adjunctive procedure, by report 579 315 $0.00
J1885 Injection, ketorolac tromethamine, per 15 mg 839 474 $0.00
J2704 Injection, propofol, 10 mg 750 433 $0.00
J3010 Injection, fentanyl citrate, 0.1 mg 616 277 $0.00
84484 114 58 $0.00
71045 Radiologic examination, chest; single view 211 111 $0.00
81001 29 16 $0.00
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 43 29 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 57 27 $0.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg 974 465 $0.00
83690 18 12 $0.00
85027 206 127 $0.00
J0690 Injection, cefazolin sodium, 500 mg 109 41 $0.00
83735 70 34 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 86 35 $0.00
59050 20 13 $0.00
86592 42 29 $0.00
94760 43 24 $0.00
87081 17 12 $0.00
86901 21 15 $0.00
83036 Hemoglobin; glycosylated (A1C) 23 12 $0.00
86850 18 13 $0.00
D0230 Intraoral - periapical each additional radiographic image 25 12 $0.00
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 27 17 $0.00
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 36 15 $0.00